|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 4 of 4
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article | Miao, Yu; Konno, Yosuke; Wang, Baojin; Zhu, Lin; Zhai, Tianyue; Ihira, Kei; Kobayashi, Noriko; Watari, Hidemichi; Jin, Xin; Yue, Junming; Dong, Peixin; Fang, Mingyan | Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer | - | Journal of Translational Medicine | - | 25-Feb-2023 |
article | Wang, Baojin; Li, Hanxuan; Zhao, Xinxin; Zhang, Wenjing; Zhao, Guannan; Wu, Zhongzhi; Zhang, Ruitao; Dong, Peixin; Watari, Hidemichi; Tigyi, Gabor; Li, Wei; Yue, Junming | A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways | - | Journal of Cancer | - | 25-Jul-2021 |
article | Wang, Baojin; Li, Xia; Zhao, Guannan; Yan, Huan; Dong, Peixin; Watari, Hidemichi; Sims, Michelle; Li, Wei; Pfeffer, Lawrence M; Guo, Yuqi; Yue, Junming | miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway | - | Journal of Experimental & Clinical Cancer Research | - | 21-Sep-2018 |
article (author version) | Zhao, Guannan; Wang, Qinghui; Wu, Zhongzhi; Tian, Xinchun; Yan, Huan; Wang, Baojin; Dong, Peixin; Watari, Hidemichi; Pfeffer, Lawrence M; Guo, Yuqi; Li, Wei; Yue, Junming | Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor | - | Molecular Cancer Therapeutics | - | Dec-2019 |
Showing results 1 to 4 of 4
|